Ginsenoside Rg1 nanoparticle penetrating the blood–brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction

Diabetic cerebral infarction is with poorer prognosis and high rates of mortality. Ginsenoside Rg1 (Rg1) has a wide variety of therapeutic values for central nervous system (CNS) diseases for the neuron protective effects. However, the blood–brain barrier (BBB) restricts Rg1 in reaching the CNS. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Junyi, Zhao, Zhiming, Shang, Wei, Liu, Chunli, Zhang, Beibei, Zhao, Lingjie, Cai, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592953/
https://www.ncbi.nlm.nih.gov/pubmed/28919749
http://dx.doi.org/10.2147/IJN.S139602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592953/
https://www.ncbi.nlm.nih.gov/pubmed/28919749
http://dx.doi.org/10.2147/IJN.S139602

Ejemplares similares